|
Volumn 217, Issue 3, 2000, Pages 163-170
|
Interim results of the prospective 'non-high-risk-penetratring keratoplasty study Erlangen' in 207 patients;Zwischenergebnisse der prospektiven 'Erlanger nicht-hochrisiko-keratoplastik-studie' bei 207 patienten
a a a a,b a a a a |
Author keywords
Immunologic graft rejection; Laser flare; Non high risk penetrating keratoplasty; Prospective study
|
Indexed keywords
STEROID;
ANTIINFLAMMATORY AGENT;
EYE DROPS;
PREDNISOLONE;
ADULT;
AGED;
ARTICLE;
CORNEA ENDOTHELIUM;
CORNEA TRANSPLANTATION;
DRUG MEGADOSE;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PENETRATING KERATOPLASTY;
PROGNOSIS;
TREATMENT INDICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORNEA DISEASE;
CORNEA OPACITY;
DRUG ADMINISTRATION;
DRUG EFFECT;
GRAFT VERSUS HOST REACTION;
IMMUNOLOGY;
KERATOMETRY;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS;
CORNEAL DISEASES;
CORNEAL OPACITY;
CORNEAL TOPOGRAPHY;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRAFT VS HOST REACTION;
HUMANS;
KERATOPLASTY, PENETRATING;
MALE;
MIDDLE AGED;
OPHTHALMIC SOLUTIONS;
PREDNISOLONE;
PROSPECTIVE STUDIES;
|
EID: 0034263704
PISSN: 00232165
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2000-10340 Document Type: Article |
Times cited : (14)
|
References (24)
|